BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37963944)

  • 1. Effects of radiotherapy on the survival of patients with stage IA and low-grade stage IB uterine endometrioid carcinoma.
    Li S; Yi Z; Li M; Zhu Z
    Sci Rep; 2023 Nov; 13(1):19883. PubMed ID: 37963944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Chemotherapy versus Radiotherapy in High-risk, Early-stage Endometrioid Endometrial Carcinoma.
    Wu M; Yang YN; Huang YH; Cai J; He XQ; Wang ZH
    Curr Med Sci; 2022 Feb; 42(1):185-191. PubMed ID: 34669113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus.
    Sahin H; Meydanli MM; Sari ME; Kocaman E; Cuylan ZF; Yalcin I; Coban G; Özen Ö; Sirvan L; Güngör T; Ayhan A
    Taiwan J Obstet Gynecol; 2019 Jan; 58(1):82-89. PubMed ID: 30638487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of vaginal brachytherapy on survival in stage I endometrioid endometrial carcinoma.
    AlHilli M; Amarnath S; Elson P; Rybicki L; Dowdy S
    Int J Gynecol Cancer; 2020 Jun; 30(6):789-796. PubMed ID: 32184268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma.
    Nagar H; Yan W; Parashar B; Nori D; Chao KS; Christos P; Gupta D; Holcomb K; Caputo T; Wernicke AG
    Am J Clin Oncol; 2016 Aug; 39(4):335-9. PubMed ID: 27028349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Adjuvant Modalities on Survival in Patients with Advanced Stage Endometrial Carcinoma: A Retrospective Analysis from a Tertiary Medical Center.
    Tai YJ; Hsu HC; Chiang YC; Chen YL; Chen CA; Cheng WF
    Int J Environ Res Public Health; 2019 Jul; 16(14):. PubMed ID: 31323767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: A National Cancer Data Base study.
    Rydzewski NR; Strohl AE; Donnelly ED; Kanis MJ; Lurain JR; Nieves-Neira W; Strauss JB
    Cancer; 2016 Dec; 122(23):3724-3731. PubMed ID: 27509082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer.
    Matsuo K; Machida H; Ragab OM; Garcia-Sayre J; Yessaian AA; Roman LD
    J Surg Oncol; 2017 Sep; 116(4):482-491. PubMed ID: 28543055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival benefit of radiation in high-risk, early-stage endometrioid carcinoma.
    Xiang M; Kidd EA
    J Gynecol Oncol; 2020 Jul; 31(4):e39. PubMed ID: 31912686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adjuvant chemotherapy in patients with FIGO stage IB grade 3 endometrial endometrioid adenocarcinoma treated with surgery and post-operative radiotherapy.
    Reshko LB; Gaskins JT; Dryden SM; Metzinger DS; Todd SL; Eldredge-Hindy HB; Silva SR
    Int J Gynecol Cancer; 2021 May; 31(5):694-701. PubMed ID: 33741653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
    Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lymphadenectomy in uterine endometrioid carcinoma.
    Huang CY; Ho CM; Chen YL; You SL; Chen CA; Cheng WF
    Eur J Surg Oncol; 2013 Apr; 39(4):350-7. PubMed ID: 23462243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB.
    Han KH; Kim HS; Lee M; Chung HH; Song YS
    Medicine (Baltimore); 2017 May; 96(21):e6976. PubMed ID: 28538399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant radiotherapy in incompletely staged IC and II endometrioid uterine cancer.
    Parthasarathy A; Kapp DS; Cheung MK; Shin JY; Osann K; Chan JK
    Obstet Gynecol; 2007 Dec; 110(6):1237-43. PubMed ID: 18055715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of complete surgical staging and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinoma.
    Swift BE; Covens A; Mintsopoulos V; Parra-Herran C; Bernardini MQ; Nofech-Mozes S; Hogen L
    Int J Gynecol Cancer; 2022 Apr; 32(4):525-531. PubMed ID: 34969829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
    Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
    Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.